Invasive Action

The Invader assay technology is Third Wave Technologies' (Madison, Wis.) isothermal, "PCR-free" approach to the detection and quantitative analysis of DNA. Instead of amplifying the target of interest, and thereby increasing the chances of "carryover" contamination, the Invader assay produces and amplifies an unrelated signal only in the presence of the correct target sequence.1 These incredibly sensitive assays can be harnessed to quantify subattomole levels of target nucleic acids within compl

Written byDeborah Wilkinson
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The Invader assay technology is Third Wave Technologies' (Madison, Wis.) isothermal, "PCR-free" approach to the detection and quantitative analysis of DNA. Instead of amplifying the target of interest, and thereby increasing the chances of "carryover" contamination, the Invader assay produces and amplifies an unrelated signal only in the presence of the correct target sequence.1 These incredibly sensitive assays can be harnessed to quantify subattomole levels of target nucleic acids within complex mixtures, and can also be used to detect genetic mutations or single nucleotide polymorphisms (SNPs) directly from genomic DNA, without the need for prior amplification of the target sequence. This technology exploits a thermostable member of the structure-specific archaebacterial flap endonuclease (FEN) family.2 These enzymes cleave nucleic acid molecules at specific sites based on structure rather than sequence. When used in conjunction with structure-forming probes for known sequences, the enzymes cleave in a structure- and target sequence-specific manner. The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies